AGIOS PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 88 SIDNEY STREET, CAMBRIDGE, MA 02139
官方登记数据
0位关注者
2008成立于
关于 AGIOS PHARMACEUTICALS, INC.
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Source: Wikipedia
行业Pharmaceutical Preparations
总部88 SIDNEY STREET, CAMBRIDGE, MA 02139
成立2008
法律形式C Corporation
状态营业中
专利515 项专利
BCAT2 INHIBITORSUS20260159512A1 · 2026
USE OF THE PYRUVATE KINASE ACTIVATOR TEBAPIVAT IN THE TREATMENT OF RENAL FIBROSIS AND OTHER RENAL DISEASESWO2026096368A1 · 2026
关键数据
法律信息
| 法定名称 | AGIOS PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1439222在 SEC EDGAR 上查看 ↗ |
| 行业代码(SIC) | 2834 |
| 注册地址 | 88 SIDNEY STREET, CAMBRIDGE, MA 02139 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026